Prediction Case File
YouTubeEvaluation Complete

Friends! In this video, I'm going to do an AMD stock analysis and talk about the risks and upside potential of AMD stock

1 extracted signal · 1 resolved · 0 still active

The Patient Investor profile imageThe Patient Investor06 Oct 2025, 20:40 UTC
Video preview for Friends! In this video, I'm going to do an AMD stock analysis and talk about the risks and upside potential of AMD stock
Signals
1
Eligible signals in this source
Open
0
Still being tracked
Resolved
1
Evaluable outcomes
Successful
0
Canonical correct result
Failed
1
Canonical failed result
Resolved success
0%
Open and excluded signals omitted
Source overview

AI-generated source summary

AMD, now termed "Advanced Money Dispenser", has surged 26% following an Open AI partnership. The analyst updates the price target to $531.66 per share based on EPS growth estimates. This is based on a 70% EPS growth in 2026 attributed to Open AI partnership, later years EPS growth: 35%, 30%, 25%, 20%. The analysis highlights the Open AI partnership as a game changer, offering AI chips to OpenAI, and potentially generating tens of billions in annual revenue. Revenue recognition will start next year. Open AI's warrants to acquire up to 10% of AMD at $0.01 per share, linked to price milestones (final tranch at $600) is designed to secure OpenAI's commitment. This amounts to massive additional revenue, as it represents about a three times the current value of share price now. The video mentions that analyst aren't fans of the warrant dilution at 1 cent per share, which is bad for market capitalization.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    1 eligible signal linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

The Patient Investor

Tracked signals
292
Historical success
32.9%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.